- Report
- April 2024
- 261 Pages
Global
From €2329EUR$2,450USD£1,957GBP
- Report
- October 2024
- 189 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- June 2024
- 190 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2025
- 193 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- January 2025
- 159 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- August 2024
- 242 Pages
Africa
From €3969EUR$4,175USD£3,334GBP
- Report
- September 2024
- 150 Pages
Asia Pacific
From €3678EUR$3,869USD£3,090GBP
- Report
- January 2023
- 178 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2024
- 141 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- September 2023
- 210 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2024
- 250 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- August 2020
- 2761 Pages
United States
From €5699EUR$5,995USD£4,788GBP
- Report
- April 2020
- 352 Pages
Russia
From €5699EUR$5,995USD£4,788GBP

The In Vitro Diagnostics (IVD) Infectious Disease market is a segment of the larger IVD industry that focuses on the diagnosis and monitoring of infectious diseases. It includes a range of products and services, such as tests for the detection of bacteria, viruses, fungi, and parasites, as well as tests for the identification of drug-resistant organisms. These tests are used to diagnose and monitor the progression of infectious diseases, as well as to guide treatment decisions.
The IVD Infectious Disease market is driven by the increasing prevalence of infectious diseases, the emergence of new and drug-resistant pathogens, and the need for rapid and accurate diagnosis. Additionally, technological advances in molecular diagnostics, such as PCR and next-generation sequencing, have enabled the development of more sensitive and specific tests.
Notable companies in the IVD Infectious Disease market include Abbott, Becton Dickinson, Roche, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more